$ANIP

$72.60 -$0.01 (0.01%) Close

$ANIP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 21.2M shares outstanding

Who owns ANIP?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 51.5%

BlackRock, Inc. 14.0% · Robert E. Brown, Jr. 4.9%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

302

+21 vs last qtr

Net shares bought

−522.9K

by institutions in Q2 2026

New / sold out

48 / 27

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

American Century Companies Inc +382.9K
Rubric Capital Management LP NEW +258.1K

Biggest sellers in Q2 2026

Goldentree Asset Management LP SOLD OUT −668.0K
Deep Track Capital, LP SOLD OUT −600.0K

Who is planning to sell?

Notices of proposed sale, last 12 months

$10.5M

15 notices from 7 people

Shares covered

134.3K

0.63% of the company

Arranged in advance

27%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Nikhil Lalwani Director $5.43M
Stephen P Carey Officer $1.99M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025

+83.4%

+6.97% a year

Each share's claim on the business

−45.5%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$36.1M vs $154M

over 10 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years48% 3–5 years11% 1–3 years26% Under 1 year16%

Quarterly turnover

13.6%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting ANIP on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	3.0M	13.98%	+211.2K (+7.7%)	≤2021	0.0%
Shares held by quarter Peak holding3.0M (Q2'26) Change over 8 quarters+268.9K Share of the company13.980% BlackRock, Inc.'s full portfolio →
SC Soleus Capital Management, L.P.	867.8K	4.10%	+47.5K (+5.8%)	2024	2.5%
Shares held by quarter Peak holding867.8K (Q2'26) Change over 8 quarters+598.8K Share of the company4.100% Soleus Capital Management, L.P.'s full portfolio →

BlackRock, Inc.

3.0M

% of company

13.98%

Change vs last qtr

+211.2K (+7.7%)

Held since

≤2021

Soleus Capital Management, L.P.

867.8K

% of company

4.10%

Change vs last qtr

+47.5K (+5.8%)

Held since

2024

28 more super investors behind a free account

See every manager holding ANI Pharmaceuticals, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ANIP on Form N-PORT; together they hold 42.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IC iShares Core S&P Small-Cap ETF iShares Trust	$91M	1.1M	5.19%	0.08%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$50.4M	609.4K	2.88%	0.00%	June 30, 2026

iShares Core S&P Small-Cap ETF

iShares Trust

Position value

$91M

% of company

5.19%

% of the fund

0.08%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$50.4M

% of company

2.88%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding ANI Pharmaceuticals, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
RE Robert E. Brown, Jr. 5%+ holder 13D · 4.8%	1.0M	4.89%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company4.890% Disclosed stake13D · 4.8% View the 13D/G filing →
MV Meridian Venture Partners II, Co. 5%+ holder 13D · 4.7%	1.0M	4.79%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company4.790% Disclosed stake13D · 4.7% View the 13D/G filing →

Robert E. Brown, Jr.

5%+ holder13D · 4.8%

1.0M

% of company

4.89%

Change vs last qtr

—

Held since

—

Meridian Venture Partners II, Co.

5%+ holder13D · 4.7%

1.0M

% of company

4.79%

Change vs last qtr

—

Held since

—

18 more holders behind a free account

See every insider and 5%+ holder of ANI Pharmaceuticals, Inc..

Comments